Even in the midst of a global pandemic, metastatic breast cancer (MBC) does not stop. It’s estimated that more than 155,000 women and men in the U.S. are living with MBC. It is Susan G Komen’s goal to ensure that policymakers understand and prioritize the needs of the women and men impacted by breast cancer, especially those living with metastatic disease.
Please enjoy Susan G Komen’s Center for Public Policy briefing on metastatic breast cancer to learn more about MBC research in the age of COVID-19, the impact of the disease on patients, and what we can do to create broad, systemic changes that improve patient outcomes.
